Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

1
Player Avatar godsend (< 20) Submitted: 1/15/2011 6:34:23 AM : Outperform Start Price: $24.53 BMY Score: +32.64

value,growth,safety,innovation.......

Report this Post Reply

Featured Broker Partners


Advertisement